REGENOVUE Sub-Q Plus

REGENOVUE Sub-Q Plus is a hyaluronic acid-based dermal filler formulated for deep tissue augmentation. It contains 24 mg/ml of non-animal stabilized HA and is intended for applications that require strong structural support, such as jawline definition, cheek enhancement, and correction of deep volume loss.

The filler is based on a monophasic gel structure with full cross-linking. The homogeneous texture allows for stable shaping and reduced migration risk, even when injected into subcutaneous layers. Compared to lighter fillers, the Sub-Q formulation is significantly denser and more viscous, making it suitable for high-lift areas that demand volume and contour retention over time.

Sub-Q Plus includes lidocaine for enhanced patient comfort during procedures. The product’s manufacturing process minimizes residual BDDE and ensures endotoxin levels remain below 0.0015 IU/mg, meeting current standards for safety and purity in aesthetic medicine.

The filler is injected into the lower subcutaneous plane, and the formulation is designed to maintain its volume for up to 18 months depending on the injection site and patient factors.

Key Features:

• Fully cross-linked HA gel with high structural density
• Homogeneous monophasic texture for precise contouring
• Reduced migration in mobile or high-volume areas
• Contains lidocaine for improved injection experience
• Free from detectable BDDE and compliant with safety thresholds
• With Lidocaine

REGENOVUE Sub-Q Plus is typically selected for structural procedures where a firm gel is required to achieve lift, shape, or durable projection, particularly in the lower face or midface areas.